Team:Tokyo Tech/Experiment/FimE dependent fim switch state assay
C4HSL-dependent growth assay
We have characterized previous parts.
contents
1. Introduction
2. Summary of the Experiment
3. Results
3.1. Arabinose dependent FimE expression
3.2. FLA analysis
4. Materials and Methods
4.1. Construction
4.2. Assay Protocol
4.2.1 Arabinose dependent FimE expression
4.2.2. FLA analysis
6. Reference
1. Introduction
ここにコピペ。
2. Summary of the Experiment
ここにコピペ。
3. Results
3.1. Arabinose dependent FimE expression
Fig.3-5-3-1 はフローサイトメーターで測定した各サンプルのヒストグラムである。レポーターセルCとDの結果から、内在性のFImBとFimEは無視できることがわかる。また、レポーターセルE,Fの結果から、FImEの発現はヒストグラムの波形にほとんど影響を与えないことがわかる。 レポーターセルAの結果は、FimEの発現量が増加すると、蛍光強度が減少することを示している。このことより、我々はFimSがFimEによってOn状態からOff状態に切り替わっていることを確信した。また、レポーターセルBの結果はFimEの発現量が増加してもレポーターセルBのGFP発現量は変化しないことを示している。これより、fimSはFimEによってOff状態からOn状態に切り替わらないことを確信した。以上二つのレポーターセルA,Bの結果より、FimEはFimSをinverts fimswitch only from ON to OFF していることを確信した。
Fig. 3-5-4-4. |
3.2. FLA analysis
写真とシークエンスデータ
4. Materials and Methods
4.1. Construction
-Strain
All the samples were DH5alpha strain.
-Plasmids
A. Pbad/araC_fimE(wild-type) (pSB6A1)+ fim switch[default ON](wild-type)_gfp (pSB3K3)
Fig. 3-5-4-1. |
B. Pbad/araC_fimE(wild-type) (pSB6A1)+ fim switch[default OFF](wild-type)_gfp (pSB3K3)
Fig. 3-5-4-2. |
C. promoter less M256ICysE(pSB6A1)+ fim switch[default ON](wild-type)_gfp(pSB3K3)…Positive control 1
Fig. 3-5-4-3. |
D. promoter less M256ICysE(pSB6A1)+ fim switch[default OFF](wild-type)_gfp(pSB3K3)…Negative control 1
Fig. 3-5-4-4. |
E. Pbad/araC-fimE (pSB6A1) +J23119 promoter_gfp (pSB3K3)…Positive control2
Fig. 3-5-4-5. |
F. Pbad/araC-fimE (pSB6A1) +promoter less gfp (pSB3K3)…Negative control2
Fig. 3-5-4-6. |
4.2. Assay Protocol
4.2.1. Arabinose dependent FimE expression
1. Prepare overnight cultures for the each sample in 3 ml LB medium, containing ampicillin (50 microg / mL), kanamycin (30 microg / mL) and glucose (final concentration of mass of glucose is 1.0 percent) at 37 ℃ for 12h.
2. Make a 1:100 dilution in 3 mL of fresh LB containing Amp, Kan and glucose (final concentration of mass of glucose is 1.0 percent).
3. Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic, and grow the cells at 37 ℃ until the observed OD590 reaches 0.4 (Fresh Culture)
4. After incubation, take 1 mL of the samples, and centrifuge at 5000x g, 1 min, 25 ℃.
5. Remove the supernatant by using P1000 pipette.
6. Suspend the pellet in 1 mL of LB containing Amp and Kan, and centrifuge at 5000x g, 1 min, 25 ℃
7. Remove the supernatant by using P1000 pipette.
8. Take the samples, and centrifuge at 5000x g, 1 min, 25 ℃.
9. Remove the supernatant by using P1000 pipette.
10. Suspend the pellet in 1 mL of LB containing Amp and Kan.
11. Add 30 microL of suspension in the following medium.
① 3 mL of LB containing Amp, Kan and 3 microL sterile water
② 3 mL of LB containing Amp, Kan and 30 microL of 500μM arabinose (final concentration of arabinose is 1 microM)
③ 3 mL of LB containing Amp, Kan and 30 microL of 1 mM arabinose (final concentration of arabinose is 2 microM)
④3 mL of LB containing Amp, Kan and 30 microL of 2 mM arabinose (final concentration of arabinose is 5 microM)
※ As for C and D, the suspension were added only in medium ① and ④.
12. Grow the samples at 37 ℃ for 6 hours.
13. Measure OD590 of all the samples every hour.
14. Start preparing the flow cytometer 1 h before the end of incubation.
15. After the incubation, take the samples, and centrifuge at 9000x g, 1min, 4℃.
16. Remove the supernatant by using P1000 pipette.
17. Add 1 mL of filtered PBS (phosphate-buffered saline) and suspend. (The ideal of OD is 0.3)
18. Dispense all of each suspension into a disposable tube through a cell strainer.
19. Use flow cytometer to measure the fluorescence of GFP. (We used BD FACSCaliburTM Flow Cytometer of Becton, Dickenson and Company.)
4.2.2. FLA analysis
1. コピペ。
2. コピペ。
3. コピペ。
4. コピペ。
5. コピペ。
6. コピペ。
7. コピペ。
8. コピペ。
9. コピペ。
5. Reference
1. Timothy S. Ham et al. (2006) A Tightly Regulated Inducible Expression System Utilizing the fim Inversion Recombination Switch. Biotechnol Bioeng 94(1):1-4